On December 20th, China Tobacco Hong Kong (06055.HK) released its positive profit announcement for the full year of 2023. According to the announcement, it is expected that China Tobacco Hong Kong and its subsidiary companies (hereinafter referred to as the "Group") will record a revenue increase of no less than 45% for the annual period ending on December 31st, 2023, and a profit increase attributable to the company's owners of no less than 50%.
The announcement highlights three main factors contributing to the growth in the group's performance. Firstly, the delayed shipments of tobacco leaves due to the impact of the pandemic have gradually arrived throughout the year. Coupled with an increase in overall selling price compared to last year, this has led to growth in the group's revenue and gross profit from the importation of tobacco products this year. Secondly, the number of cross-border tourists has gradually increased as global pandemic control measures have been relaxed, leading to a significant growth in cigarette exports as consumption in the group's duty-free shops within the operating region has recovered. Additionally, the disruption in the shipping schedule has resulted in a substantial increase in sales of high-gross-margin tobacco by-products compared to the previous year, leading to significant growth in the group's revenue and gross profit from its operations in Brazil.
As the only tobacco-based company under China Tobacco Corporation, China Tobacco Hong Kong has always adhered to its strategic positioning as a "capital operation platform" and an "international business expansion platform". The group's performance has maintained steady and robust growth, with strong financial indicators and an increasing trend in dividend distribution. It is believed that the group will continue to actively seize market opportunities, adhere to the dual-drive development strategy of external expansion and internal growth, and create more value for shareholders in the future.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
